Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle.
Ontology highlight
ABSTRACT: This article will review myogenic cell transplantation for congenital and acquired diseases of skeletal muscle. There are already a number of excellent reviews on this topic, but they are mostly focused on a specific disease, muscular dystrophies and in particular Duchenne Muscular Dystrophy. There are also recent reviews on cell transplantation for inflammatory myopathies, volumetric muscle loss (VML) (this usually with biomaterials), sarcopenia and sphincter incontinence, mainly urinary but also fecal. We believe it would be useful at this stage, to compare the same strategy as adopted in all these different diseases, in order to outline similarities and differences in cell source, pre-clinical models, administration route, and outcome measures. This in turn may help to understand which
SUBMITTER: Boyer O
PROVIDER: S-EPMC8365145 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA